LABORATORY RESEARCH Effect of Actin Organization on the Stiffness of Living Breast Cancer Cells Revealed by Peak-Force Modulation Atomic Force Microscopy Researchers studied the correlation between cytoskeleton organization and stiffness of three epithelial breast cancer cells lines with different degree of malignancy: MCF-10A (healthy), MCF-7 (tumorigenic/non-invasive) and MDA-MB-231 (tumorigenic/invasive). [ACS Nano] Abstract TOM1L1 Drives Membrane Delivery of MT1-MMP to Promote ERBB2-Induced Breast Cancer Cell Invasion Investigators demonstrated that TOM1L1 upregulation enhances the invasiveness of ERBB2-transformed cells. This pro-tumoral function did not involve SRC, but implicated membrane-bound membrane-type 1 MMP (MT1-MMP)-dependent activation of invadopodia, membrane protrusions specialized in extracellular matrix degradation. [Nat Commun] Full Article In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors Researchers established an in vivo approach to track the fate of tumor cells based on a novel epithelial-to-mesenchymal transition-driven fluorescent color switching breast cancer mouse model and intravital two-photon laser scanning microscopy. [Cancer Res] Abstract Mitochondrial Reprogramming Regulates Breast Cancer Progression Scientists characterized the critical components regulating mitochondrial function in breast tumorigenesis. Experiments were conducted to assess the potential of these molecules for exosome based biomarker development. [Clin Cancer Res] Abstract Therapeutic siRNA for Drug-resistant HER2-Positive Breast Cancer The authors systematically identified an optimal HER2 siRNA from 76 potential sequences and demonstrated its utility in overcoming intrinsic and acquired resistance to trastuzumab and lapatinib in 18 HER2-positive cancer cell lines. [Oncotarget] Full Article Suicide Gene-Engineered Stromal Cells Reveal a Dynamic Regulation of Cancer Metastasis Researchers observed that the selective apoptosis of cancer-associated fibroblasts at early timepoints did not affect primary tumor growth, but instead increased the presence of tumor-associated macrophages and the metastatic spread of breast cancer cells to the lung and bone. [Sci Rep] Full Article | Press Release Glucose Is a Key Driver for GLUT1-Mediated Nanoparticles Internalization in Breast Cancer Cells The authors demonstrated that the uptake of glucose-coated magnetic nanoparticles (MNPs) by mesenchymal-like cells remains constant when the glucose in the medium is increased from low to high concentration, while the MNPs uptake by epithelial-like cells is significantly reduced. [Sci Rep] Full Article Interferon-Induced Transmembrane Protein 1 (IFITM1) Overexpression Enhances the Aggressive Phenotype of SUM149 Inflammatory Breast Cancer Cells in a Signal Transducer and Activator of Transcription 2 (STAT2)-Dependent Manner Scientists found that IFITM1 was constitutively overexpressed at the mRNA and protein levels in triple-negative SUM149 inflammatory breast cancer (IBC) cells, but that it was not expressed in SUM190 and MDA-IBC-3 IBC cells, and that suppression of IFITM1 or blockade of the IFNα signaling pathway significantly reduced the aggressive phenotype of SUM149 cells. [Breast Cancer Res] Full Article CXCR4-SDF-1 Interaction Potentially Mediates Trafficking of Circulating Tumor Cells in Primary Breast Cancer Investigators aimed to assess correlation between CTCs and plasma cytokines in primary breast cancer (PBC) patients.The study included 147 chemotherapy naïve PBC patients. [BMC Cancer] Full Article CLINICAL RESEARCH Phase II Study on the Efficacy and Safety of Lapatinib Administered Beyond Disease Progression and Combined with Vinorelbine in HER-2/neu- Positive Advanced Breast Cancer: Results of the CECOG LaVie Trial Researchers evaluated the efficacy and safety of vinorelbine when combined with lapatinib, an anti-HER2 tyrosine-kinase inhibitor, as late-line regimen administered beyond previous disease progression on prior lapatinib in patients with HER-2/neu- positive metastatic breast cancer. [BMC Cancer] Full Article |